BioSpace News Archive

Avanos Medical, Inc. reported fourth quarter and full-year 2018 results.

Verastem, Inc. announced that the Company will host a conference call and webcast on Tuesday, March 12, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter and year ended December 31, 2018.

Rocket Pharmaceuticals, Inc. announces the online publication of a comprehensive literature review of published Danon disease cases in the International Journal of Cardiology, co-authored by Eric Adler, M.D., Director of Cardiac Transplant and Mechanical Circulatory Support at UC San Diego Health and Professor of Medicine at University of California San Diego School of Medicine.

In 2018, Oregon school districts that used the STEMscopes™ NGSS digital science curriculum with their fifth grade students showed higher proficiency rates on the state science assessment than districts that did not use STEMscopes, according to a new study published by Accelerate Learning.

Premier Health Group, a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it is growing its development team at Cloud Practice Inc.

--Stoke Therapeutics and Xenon Pharmaceuticals Join Founders BioMarin and Invitae to Offer a No-Cost Epilepsy Gene Panel Testing Program for Children Up to 60 Months Who Have Had an Unprovoked Seizure-- [26-February-2019] SAN FRANCISCO , Feb. 26, 2019 /PRNewswire/ -- As Rare Disease Day focuses attention on the challenges of diagnosing rare, often genetic conditions,

New state-of-the-art facility is cornerstone of Gary and Mary West’s philanthropic efforts to improve emergency care for seniors across the country

Health Care Service Corporation (HCSC) has been recognized by the Ethisphere Institute as a 2019 World’s Most Ethical Company®.

PerfectServe®, a leading provider of cloud-based clinical communication and collaboration (CC&C) solutions, recently hosted the fifth annual meeting of its Customer Advisory Board (CAB)

Thermo Fisher Scientific today announced that the Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency, has granted expanded approval to the Oncomine Dx Target Test CDx System.